[1]
“The comparative assessment of single dose versus co-administration of salinomycin and MK-2206 on viability, apoptosis, and gene expression of human prostate cancer cells”, J Curr Biomed Rep, vol. 1, no. 1, pp. 1–7, Mar. 2023, doi: 10.61186/jcbior.4.1.197.